INNOVIVA, INC. Earnings Per Share, Basic and Diluted
INNOVIVA, INC. (INVA) reported Earnings Per Share, Basic and Diluted of $0.24 per share for the 3-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2017-02-28
- INNOVIVA, INC. earnings per share, basic and diluted for the quarter ending 2016-12-31 was $0.24, a 500.00% increase year-over-year.
- INNOVIVA, INC. earnings per share, basic and diluted for the quarter ending 2016-09-30 was $0.14.
- INNOVIVA, INC. earnings per share, basic and diluted for the quarter ending 2016-06-30 was $0.13.
- INNOVIVA, INC. earnings per share, basic and diluted for the quarter ending 2016-03-31 was $0.04.
- INNOVIVA, INC. earnings per share, basic and diluted for fiscal 2015 was -$0.16.
- INNOVIVA, INC. earnings per share, basic and diluted for fiscal 2014 was -$1.50.
- INNOVIVA, INC. earnings per share, basic and diluted for fiscal 2013 was -$1.67.
- INNOVIVA, INC. earnings per share, basic and diluted for fiscal 2012 was -$0.20.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.24 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $0.14 10-K · filed 2017-02-28 | |||
| 2016-06-30 | $0.13 10-K · filed 2017-02-28 | $0.17 10-Q · filed 2016-08-04 | ||
| 2016-03-31 | $0.04 10-K · filed 2017-02-28 | |||
| 2015-12-31 | $0.04 10-K · filed 2017-02-28 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-02-28 | -$0.07 derived: net income ÷ weighted average shares · filed 2017-02-28 | -$0.16 10-K · filed 2016-02-24 |
| 2015-09-30 | -$0.04 10-K · filed 2017-02-28 | -$0.11 derived: net income ÷ weighted average shares · filed 2017-02-28 | -$0.20 10-Q · filed 2015-11-05 | -$0.34 derived: net income ÷ weighted average shares · filed 2017-02-28 |
| 2015-06-30 | -$0.07 10-K · filed 2017-02-28 | -$0.16 10-Q · filed 2016-08-04 | -$0.30 derived: net income ÷ weighted average shares · filed 2017-02-28 | -$0.49 derived: net income ÷ weighted average shares · filed 2017-02-28 |
| 2015-03-31 | -$0.09 10-K · filed 2017-02-28 | -$0.23 derived: net income ÷ weighted average shares · filed 2017-02-28 | -$0.42 derived: net income ÷ weighted average shares · filed 2017-02-28 | -$0.98 derived: net income ÷ weighted average shares · filed 2017-02-28 |
| 2014-12-31 | -$0.14 10-K · filed 2016-02-24 | -$0.33 derived: net income ÷ weighted average shares · filed 2016-02-24 | -$0.89 derived: net income ÷ weighted average shares · filed 2016-02-24 | -$1.50 10-K · filed 2016-02-24 |
| 2014-09-30 | -$0.19 10-K · filed 2016-02-24 | -$0.76 derived: net income ÷ weighted average shares · filed 2016-02-24 | -$1.37 10-Q · filed 2015-11-05 | -$1.83 derived: net income ÷ weighted average shares · filed 2016-02-24 |
| 2014-06-30 | -$0.57 10-K · filed 2016-02-24 | -$1.19 10-Q · filed 2015-08-06 | -$1.65 derived: net income ÷ weighted average shares · filed 2016-02-24 | -$2.09 derived: net income ÷ weighted average shares · filed 2016-02-24 |
| 2014-03-31 | -$0.62 10-K · filed 2016-02-24 | -$1.08 derived: net income ÷ weighted average shares · filed 2016-02-24 | -$1.52 derived: net income ÷ weighted average shares · filed 2016-02-24 | -$1.90 derived: net income ÷ weighted average shares · filed 2016-02-24 |
| 2013-12-31 | -$0.46 10-K · filed 2015-02-27 | -$0.90 derived: net income ÷ weighted average shares · filed 2016-02-24 | -$1.28 derived: net income ÷ weighted average shares · filed 2016-02-24 | -$1.67 10-K · filed 2016-02-24 |
| 2013-09-30 | -$0.44 10-K · filed 2015-02-27 | -$0.82 derived: net income ÷ weighted average shares · filed 2015-02-27 | -$1.20 10-Q · filed 2014-11-04 | |
| 2013-06-30 | -$0.37 10-K · filed 2015-02-27 | -$0.76 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | -$0.39 10-K · filed 2015-02-27 | |||
| 2012-12-31 | -$0.20 10-K · filed 2015-02-27 | |||
| 2011-12-31 | -$1.41 10-K · filed 2014-03-03 | |||
| 2011-09-30 | -$0.37 10-Q · filed 2011-11-02 | -$0.96 10-Q · filed 2011-11-02 | ||
| 2011-06-30 | -$0.31 10-Q · filed 2011-08-03 | -$0.59 10-Q · filed 2011-08-03 | ||
| 2010-12-31 | -$1.16 10-K · filed 2013-02-26 | |||
| 2010-09-30 | -$0.29 10-Q · filed 2011-11-02 | -$0.91 10-Q · filed 2011-11-02 | ||
| 2010-06-30 | -$0.28 10-Q · filed 2011-08-03 | -$0.63 10-Q · filed 2011-08-03 | ||
| 2009-12-31 | -$1.35 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |